Assistance

To Request Assistance from the CCTO:

Cancer center investigators should contact Miriam Bischoff, Facility Director, CCTO, regarding new requests for assistance with study services. Requests will be prioritized, and assigned to an appropriate staff member. Once assigned, research personnel are encouraged to interact directly with the CCTO staff member. Fees for CCTO services are charged to the study sponsor when appropriate. Miriam can be contacted at mbischoff@stanford.edu or 650-498-4536.

To reserve a space for a study monitor visit, or to arrange a tour of the cancer center for an industry sponsor, send email to or call 650-724-9809.

New Protocol Submission:

All protocols are submitted to the CCTO so they can be registered and tracked. The CCTO works closely with the Protocol Review and Monitoring System (PRMS) Core to expedite scientific review of new protocols. To register a new protocol with the CCTO, please follow the procedures in the Summary of Steps for Protocol Submission.

Refer to ICD-O-3 Disease Site Codes and ICD-O-3 Histology Codes for completing the New Protocol Registration Form, and the Subject Registration Form mentioned below.

To Report an Adverse Event:

The Data and Safety Monitoring Committee (DSMC) is required to review all SAEs. Report all Adverse Events to Lee Doherty, Regulatory Specialist, lee.doherty@stanford.edu 650-736-0176 in the Cancer Clinical Trials Office. She will submit these reports to the IRB, DSMC, and all other required regulatory entities in a timely manner. Please complete the Adverse Event Communication Form to submit with your reports. See the Adverse Event Reporting Procedures.